Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1916 1
1945 1
1947 2
1955 1
1956 1
1957 1
1958 1
1959 1
1963 2
1979 1
1982 1
1984 1
1990 1
1992 1
1993 1
1994 4
1995 6
1996 1
1997 5
1998 1
1999 8
2000 5
2001 8
2002 3
2003 6
2004 8
2005 4
2006 6
2007 8
2008 7
2009 7
2010 10
2011 15
2012 14
2013 10
2014 10
2015 4
2016 11
2017 14
2018 8
2019 8
2020 20
2021 8
2022 7
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 29920121

233 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa.
Vesikari T, Rivera L, Korhonen T, Ahonen A, Cheuvart B, Hezareh M, Janssens W, Mesaros N. Vesikari T, et al. Hum Vaccin Immunother. 2017 Jul 3;13(7):1505-1515. doi: 10.1080/21645515.2017.1294294. Epub 2017 Mar 24. Hum Vaccin Immunother. 2017. PMID: 28340322 Free PMC article. Clinical Trial.
Immunization of preterm infants with GSK's hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicity.
Omeñaca F, Vázquez L, Garcia-Corbeira P, Mesaros N, Hanssens L, Dolhain J, Gómez IP, Liese J, Knuf M. Omeñaca F, et al. Vaccine. 2018 Feb 8;36(7):986-996. doi: 10.1016/j.vaccine.2018.01.005. Epub 2018 Jan 12. Vaccine. 2018. PMID: 29336924 Free article. Review.
Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States.
Klein NP, Abu-Elyazeed R, Cheuvart B, Janssens W, Mesaros N. Klein NP, et al. Hum Vaccin Immunother. 2019;15(4):809-821. doi: 10.1080/21645515.2018.1549449. Epub 2019 Jan 4. Hum Vaccin Immunother. 2019. PMID: 30444673 Free PMC article. Clinical Trial.
Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered as a single injection, with the DTPa-IPV/Hib and hepatitis B vaccines administered in two simultaneous injections to infants at 2, 4 and 6 months of age.
Arístegui J, Dal-Ré R, Díez-Delgado J, Marés J, Casanovas JM, García-Corbeira P, De Frutos E, Van Esso D, Verdaguer J, De la Flor J, Moraga F, Boceta R, García-Martínez JA. Arístegui J, et al. Vaccine. 2003 Sep 8;21(25-26):3593-600. doi: 10.1016/s0264-410x(03)00420-1. Vaccine. 2003. PMID: 12922087 Clinical Trial.
Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine.
Cheng HK, Rajadurai VS, Amin Z, Sriram B, Yee MF, Han HH, Bock HL, Safary A. Cheng HK, et al. Southeast Asian J Trop Med Public Health. 2004 Sep;35(3):685-92. Southeast Asian J Trop Med Public Health. 2004. PMID: 15689088 Clinical Trial.
A randomized, dose-ranging assessment of the immunogenicity and safety of a booster dose of a combined diphtheria-tetanus-whole cell pertussis-hepatitis B-inactivated poliovirus-Hemophilus influenzae type b (DTPw-HBV-IPV/Hib) vaccine vs. co-administration of DTPw-HBV/Hib and IPV vaccines in 12 to 24 months old Filipino toddlers.
Quiambao B, Van Der Meeren O, Kolhe D, Gatchalian S. Quiambao B, et al. Hum Vaccin Immunother. 2012 Mar;8(3):347-54. doi: 10.4161/hv.18630. Epub 2012 Feb 14. Hum Vaccin Immunother. 2012. PMID: 22330958 Free PMC article. Clinical Trial.
233 results